SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000893220-06-000556
Filing Date
2006-03-15
Accepted
2006-03-15 17:26:49
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 PAR PHARMACEUTICAL COMPANIES, INC. w18556e10vk.htm 10-K 1395748
2 LIST OF SUBSIDIARIES OF THE REGISTRANT w18556exv21.htm EX-21 7015
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER w18556exv31w1.htm EX-31.1 8544
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER w18556exv31w2.htm EX-31.2 8211
5 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 w18556exv32w1.htm EX-32.1 3401
6 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 w18556exv32w2.htm EX-32.2 3047
  Complete submission text file 0000893220-06-000556.txt   1427476
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-10827 | Film No.: 06689222
SIC: 2834 Pharmaceutical Preparations